Senile osteoporosis: Is it an immune-mediated disease?

Inflammation Research

Volumn 55, Issue 10, 2006, Pages 399-404

  De Martinis, M ^a   Di Benedetto, M C ^a   Mengoli, L P ^a   Ginaldi, L ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; ESTROGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA;

AGING; BONE REMODELING; BONE TURNOVER; HORMONE ACTION; HORMONE DEFICIENCY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; OSTEOCLAST; PROTEIN FUNCTION; REVIEW; SENESCENCE; SENILE OSTEOPOROSIS; SENILITY; TH1 CELL; TH2 CELL;

AGING; BONE REMODELING; HUMANS; INFLAMMATION; OSTEOPOROSIS; POSTMENOPAUSE; TH1 CELLS; TH2 CELLS;

EID: 33751106906     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-6034-x     Document Type: Review

References (59)

1. Arron JR, Choi Y. Bone versus immune system. Nature 2000; 408: 535-6.
2. Goldring SR. Inflammatory mediators as essential elements in bone remodelling. Calcif Tissue Int 2003; 73: 97-100.
3. Ginaldi L, Di Benedetto MC, De Martinis M. Osteoporosis, inflammation and ageing. Immun Ageing 2005; 2: 14.
4. Yun AJ, Lee PY. Maladaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosis. Med Hypotheses 2004; 63: 532-7.
5. Lorenzo J. Interactions between immune and bone cells: new insights with many remaining questions. J Clin Invest 2000; 106: 749-52.
6. Delmas PD. Treatment of postmenopausal osteoporosis. Lancet 2002; 359: 2018-26.
7. Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002; 20: 795-823.
8. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005; 579: 2035-9.
9. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E et al. Inflamm-ageing. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000; 908: 244-54.
10. Ginaldi L, De Martinis M, Monti D, Franceschi C. Chronic antigenic load and apoptosis in immunosenescence. Trends Immunol 2005; 26: 79-84.
11. Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw 2002; 13: 389-91.
12. Nanes MSL. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003; 4: 1-15.
13. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21: 115-37.
14. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 2000; 106: 1229-37.
15. Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 1989; 86: 2398-402.
16. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JC et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 88-91.
17. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 2005; 115: 282-90.
18. Walsh NC, Gravallese EM. Bone loss in inflammatory arthritis: mechanisms and treatment strategies. Curr Opin Rheumatol 2004; 16: 419-27.
19. Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, de Vernejoul MC, Boissier MC, Cohen-Solal ME. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 2004; 35: 1200-7.
20. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-53.
21. Hirose K, Tomiyama H, Okazaki R, Arai T, Koji Y, Zaydun G et al. Increased pulse wavevelocity associated with reduced calcaneal quantitative osteo-sono index: possible relationship between atherosclerosis and osteopenia. J Clin Endocrinol Metab 2003; 88: 2573-8.
22. Redker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin 2003; 21: 315-25.
23. Koh J-M, Khang Y-H, Jung C-H, Bae S, Kim DJ, Chung Y-E et al. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporosis International 2005; 16: 1263-71.
24. Giangregorio L, Blimkie CJ. Skeletal adaptations to alterations in weight-bearing activity: a comparison of models of disuse osteoporosis. Sports Med 2002; 32: 459-76.
25. Pape HC, van Griensven M, Rice J, Gansslen A, Hildebrand F, Zech S et al. Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical markers. J Trauma 2001; 50: 989-1000.
26. Pape HC, Schmidt RE, Rice J, van Griensven M, das Gupta R, Krettek C et al. Biochemical changes after trauma and skeletal surgery of the lower estremity: quantification of the operative burden. Crit Care Med 2000; 28: 3441-8.
27. Bergamini E. Targets for antiageing drugs. Expert Opin Ther Targets 2005; 9: 77-82.
28. Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K. Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc 2005; 97: 329-33.
29. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003; 6: 295-9.
30. Pfeilschifter J. Role of cytokines in postmenopausal bone loss. Curr Osteoporos Rep 2003; 1: 53-8.
31. Siggelkow H, Eidner T, Lehmann G, Viereck V, Raddarz D, Munzel U et al. Cytokines, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone diseases. J Bone Miner Res 2003; 18: 529-38.
32. Muller B. Cytokine imbalance in non immunological chronic disease. Cytokine 2002; 18: 334-9.
33. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001; 142: 5050-5.
34. Armour KJ, Armour KE, van't Hof RJ, Reid DM, Wei XQ, Liew FY et al. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 2001; 44: 2790-6.
35. Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NFkappa B ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 2002; 30: 340-6.
36. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 2003; 111: 1221-30.
37. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-76.
38. Yasuda H, Shima N, Nagakawa N, Yamaguchi K, Kinosaki M, Mochizuchi S et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95: 3597-602.
39. Saidenberg-Kermanac'h N, Cohen-Solal M, Bessis N, De Vernejoul MC, Boissier MC. Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine 2004; 71: 9-31.
40. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 2001; 166: 4915-21.
41. Abu-Amer Y. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappa B. J Clin Invest 2001; 107: 1375-85.
42. Wu H, Arron JR. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. BioEssays 2003; 25: 1096-105.
43. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K et al. T-cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000; 408: 600-5.
44. Berg G, Ekerfelt C, Hammar M, Lindgren R, Matthiesen L, Ernerudh J. Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study. Am J Reprod Immunol 2002; 48: 63-9.
45. Schubert M, Bullmann C, Minnemann T, Reiners C, Krone W, Jockenhovel F. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secundary hypogonadism. Horm Res 2003; 60: 21-8.
46. Moffett SP, Zmuda JM, Oakley JI, Beck TJ, Cauley JA, Stone KL et al. Tumor necrosis factor-alpha polymorphism, bone strenght phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab 2005; 90: 3491-7.
47. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90-119.
48. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel MJ, Ziegler R et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade post menopause. J Clin Endocrinol Metab 2001; 86: 2032-12.
49. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999; 25: 255-9.
50. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis 1999; 5: 285-94.
51. Doganci A, Sauer K, Karwot R, Finotto S. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin Rev Allergy Immunol 2005; 28: 257-70.
52. Sandmand M, Bruunsgaard H, Kemp K, Andersen-Ronberg K, Pedersen AN, Skinhoj P et al. Is ageing associated with a shift in the balance between type 1 and type 2 cytokines in humans? Clin Exp Immunol 2002; 127: 107-14.
53. Ginaldi L, De Martinis M, D' Ostilio A, Marini L, Loreto MF, Quaglino D. The immune system in the elderly: III.Innate immunity Immunol Res 1999; 20: 117-26.
54. Cioffi M, Esposito K, Vietri MT, Gazzerro P, D'Auria A, Ardovino I et al. Cytokine pattern in postmenopause. Maturitas 2002; 41: 187-92.
55. Peris P, Guanabens N, Monegal A, Pons F, Martinez de Osaba MJ, Ros I et al. Pregnancy associated osteoporosis: the familial effect. Clin Exp Rheumatol 2002; 20: 697-700.
56. Lee WY, Kang MI, Oh ES, Oh KW, Han JH, Cha BY et al. The role of cytokines in the changes in bone turnover following bone marrow transplantation. Osteoporos Int 2002; 13: 62-8.
57. Ostrowski SR, Gerstoft J, Pedersen BK, Vellum H. Impaired production of cytokines is an independent predictor of mortality in HIV-1 infected patients. Aids 2003; 17: 521-30.
58. Mondy K, Tebas P. Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis 2003; 36: 101-5.
59. Segal E, Baruch Y, Kramsky R, Raz B, Tamir A, Ish-Shalom S. Predominant factors associated with bone loss in liver transplant patients after prolonged post-transplantation period. Clin Transplant 2003; 17: 13-9.